Poster Presentations: Tuesday, November 2, 2010 |

Effect of Imatinib and Nilotinib on Bleomycin-Induced Acute Lung Injury and Pulmonary Fibrosis FREE TO VIEW

Hyoung Kyu Yoon, MD; Sang Haak Lee, MD; Yong Hyun Kim; Seok Chan Kim, MD; Chi Hong Kim, MD; Young Kyoon Kim, MD; Hwa Sik Moon, MD; Joong Hyeun Ahn, MD; Sung Hak Park, MD; Jin Woo Kim
Author and Funding Information

Catholic University of Medical Center, Uijongbu, South Korea

Chest. 2010;138(4_MeetingAbstracts):221A. doi:10.1378/chest.10166
Text Size: A A A
Published online


PURPOSE: To demonstrate this effect, we evaluated (1) The effects of imatinib/nilotinib on acute lung injury and fibrotic changes induced by bleomycin (2) The effects on the signal transduction pathway responsible for inflammatory and fibrotic responses To see the sequential change of lung injury and fibrosis, we examined animal model on day 3, 7, 14 and 21.

METHODS: Animalmale C57BL6 mice, 6 weeks of age(1) Control(2) Bleomycin (3) Bleomycin + Imatinib(100mg/kg, twice-daily)(4) Bleomycin + Nilotinib(100mg/kg, once-daily)In vitro studyNIH3T3Fibroblast0703 \Bleomycin Administrated via intratracheal instillation (1.5 U/kg) on day 0Imatinib / nilotinib administrated by oral gavage Starting on 3 days before bleomycin administration continuing till sacrifice. Sacrifice On days 3, 7, 14, and 21 BALF cell count analysisELISA in BALF : TGF-β1, IL-6, IL-1β, TNF-α Collagen assay in lung tissue : hydroxyproline Western in lung tissue : p-Smad 2,3,7, TGF-β1, PDGFR-βRT-PCR in lung tissue : TGF-β1, PDGFRT-PCR in cell line : PDGF-AA, PDGF-BB.

RESULTS: Histological examination showed imatinib and nilotinib attenuated lung injury and fibrosis. The number of inflammatory cells and levels of interleukin (IL)-6, IL-1β and tumor necrosis factor (TNF)-α were decreased in imatinib and nilotinib group on days 3 and 7. Imatinib and nilotinib therapy significantly reduced the levels of hydroxyproline and transforming growth factor (TGF)-β1 on days 14 and 21, which was accompanied by the decreased expression of TGF-β1 and PDGFR-β. Imatinib and nilotinib also significantly reduced the gene expression of TGF-β1 and PDGF. In vitro experiment, imatinib and nilotinib significantly inhibited the PDGF-induced proliferation of lung fibroblasts.

CONCLUSION: Imatinib&nilotinib attenuated bleomycin-induced ALI on day 3&7Imatinib&nilotinib attenuated bleomycin-induced pulmonary fibrosis on day 14&21Further investigation is needed into the mechanisms through which pravastatin inhibits ALI and pulmonary fibrosis.

CLINICAL IMPLICATIONS: Imatinib&nilotinib are potential treatment strategy for acute lung injury and fibrosis.

DISCLOSURE: Jin Woo Kim, No Financial Disclosure Information; No Product/Research Disclosure Information

12:45 PM - 2:00 PM




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543